The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay device

Abstract Background Rapid and accurate diagnosis of individuals with SARS-CoV-2 infection is an effective way to prevent and control the spread of COVID-19. Although the detection of SARS‐CoV‐2 viral RNA by RT‐qPCR is the gold standard for COVID-19 testing, the use of antigen-detecting rapid diagnos...

Full description

Bibliographic Details
Published in:BMC Immunology
Main Authors: Kengo Nishimura, Hiroaki Kitazawa, Takashi Kawahata, Kosuke Yuhara, Takahiro Masuya, Toshihiro Kuroita, Kentarou Waki, Seiichi Koike, Masaharu Isobe, Nobuyuki Kurosawa
Format: Article
Language:English
Published: BMC 2023-09-01
Subjects:
SARS-CoV-2
COVID-19
Omicron
Rapid antigen test
Point-of-care test
Monoclonal antibody
Online Access:https://doi.org/10.1186/s12865-023-00567-y

Internet

https://doi.org/10.1186/s12865-023-00567-y

Similar Items